Sort by
Keyphrases
Acute COVID-19
5%
Acute Disease
5%
Acute Phase
5%
Adult Patients
5%
Anti-SARS-CoV-2 Antibodies
10%
Antibodies to SARS-CoV-2
5%
Anxiety-depression
5%
Arthralgia
5%
Article 11
5%
Autonomic Symptoms
5%
Biosensing
16%
Clinical Characteristics
5%
COMPASS-31
5%
Consecutive Patients
5%
Cost-effectiveness
16%
COVID-19
10%
Diarrhea
10%
Digestive
10%
Dyspnea
5%
Electrochemiluminescence Immunoassay (ECLIA)
5%
Fatigue Muscles
5%
First Symptom
5%
Higher Education
16%
Human Resources
16%
Humoral Response
5%
Impaired Concentration
5%
Inter-individual Variability
5%
International Missions
16%
International Publication
16%
International Scientific Collaboration
16%
Literature Analysis
5%
Long-term Immune Response
5%
Meta-analysis
10%
Multiorgan Involvement
16%
Multivariate Methods
5%
Muscle Discomfort
5%
Muscle Pain
5%
Muscle Weakness
5%
Musculoskeletal Involvement
5%
Neurological Involvement
5%
Neurological Symptoms
5%
Non-associated
5%
Polyautoimmunity
16%
Post-COVID Syndrome
100%
Post-COVID-19
10%
Previous Hospitalization
5%
Primary Prevention
16%
PRISMA Guidelines
5%
Pulmonary Involvement
5%
SARS-CoV-2 Infection
10%
Scientific Level
16%
Secondary Prevention
16%
Serum Antibody
5%
Sickness Response
5%
Structured Survey
5%
Systematic Literature Review
5%
Technological Level
16%
Therapeutic Potential
5%
Total IgG
5%
Translational Model
50%
Transnational
16%
Univariate Methods
5%
Validated Survey
5%
Wise Man
16%
Zung Scale
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Disease
5%
Arthralgia
5%
Diarrhea
10%
Dyspnea
5%
Immunoassay
5%
Immunoglobulin A
5%
Immunoglobulin M
5%
Infection
10%
Muscle Weakness
5%
Neurologic Disease
5%
SARS Coronavirus
30%
Syndrome
50%